Day: December 21, 2018

More Losses Leave US Markets With Worst Week in 7-Plus Years

After almost 10 years, Wall Street’s rally looks like it’s ending. 

Another day of big losses Friday left the U.S. market with its worst week in more than seven years. All of the major indexes have lost 16 to 26 percent from their highs this summer and fall. Barring huge gains during the upcoming holiday period, this will be the worst December for stocks since 1931. 

 

There hasn’t been one major shock that has sent stocks plunging. The U.S. economy has been growing since 2009, and most experts think it will keep expanding for now. But it’s likely to do so at a slower pace. 

 

As they look ahead, investors are finding more and more reasons to worry. The U.S. has been locked in a trade dispute with China for nine months. Economies in Europe and China are slowing. And rising interest rates in the U.S. could slow its economy even more. 

Dreadful month

 

Stocks are now headed for their single worst month since October 2008, when the market was being battered by the global financial crisis. 

 

December is generally the strongest time of the year for U.S. stocks. Traders often talk about a “Santa rally” that adds to the year’s gains as people adjust their portfolios in anticipation of the year to come.  

  

But not this year. 

 

No sector of the market has been spared. Large multinational companies join smaller domestic ones in their losses. And huge high-tech companies, once the best-performing stocks on the market, are now leading the way lower.  

  

Technology’s huge popularity during the recent boom years made it even more vulnerable as investors’ moods turn sour. Amazon, Facebook, Apple, Netflix and Google’s parent company, Alphabet, have seen their market values fall by hundreds of billions of dollars. 

 

“If you live by momentum, you die by momentum,” said Sam Stovall, chief investment strategist for CFRA. 

 

The Nasdaq composite, which contains a high concentration of tech stocks, has sunk almost 22 percent from its record high in late August. Several big technology companies, notably Facebook and Twitter, have also suffered as a result of scandals over matters such as data privacy and election meddling, and traders worry that the industry will face greater government regulation that could increase costs and affect their profits. 

 

The major U.S. indexes fell 7 percent this week and they’ve sunk more than 12 percent in December. 

Global slowdown

 

Investors around the world have grown increasingly pessimistic about the global economy’s prospects over the next few years. It’s widely expected to slow down, but traders are concerned the cooling might be worse than they previously believed.  

  

After a sharp early gain Friday, the S&P 500 index retreated 50.84 points, or 2.1 percent, to 2,416.58. The S&P 500, the benchmark for many index funds, has fallen 17.5 percent from its high in September. 

 

The Dow Jones industrial average sank 414.23 points, or 1.8 percent, to 22,445.37. The Nasdaq skidded 195.41 points, or 3 percent, to 6,332.99. The Russell 2000 index of smaller-company stocks lost 33.92 points, or 2.6 percent, to 1,292.09. 

 

European markets rose slightly and Asian markets were mixed.  

  

The price of oil has also fallen sharply in recent weeks, down 40 percent from the high it reached in October, amid concerns over a glut in the market and the slowing economy. 

 

On Friday the price of U.S. crude slipped 0.6 percent to $45.59 a barrel in New York. Brent crude, the standard for international oil prices, fell 1 percent to $53.82 a barrel in London. 

more

Most Babies Born With Cleft Condition Could Die Without Surgery

One of the most common birth defects in the world is a cleft lip. It’s essentially a gap in the upper lip where the skin didn’t grow together. Babies with cleft lips may also have a cleft palates, where the roof of the mouth is split. Both can be repaired surgically. But unless that’s done, this birth defect can cause significant disability or even death. More from VOA’s Carol Pearson.

more

Tons of Dead Fish Wash Up in Rio de Janeiro Lagoon

Residents of a high-end neighborhood in Rio de Janeiro woke up to the unpleasant smell of 13 tons of rotting dead fish floating in the city’s Rodrigo de Freitas lagoon.

Biologists believe the extreme heat caused by El Nino killed the fish overnight and caused them to wash ashore Friday.

The lagoon played host to several events during the 2016 Olympic games and is a tourist attraction.

Rio’s environment ministry released a statement saying it has been on alert since Thursday morning when oxygen levels in the body of water began to fall sharply.

Biologist and ecosystem specialist Mario Moscatelli says that he inspects the lagoon every year and is convinced that climate change is causing temperature increases.

more

Canadian Economy Exceeds Expectations in October

The Canadian economy expanded by a greater-than-expected 0.3 percent in October from September, pushed higher by strength in manufacturing, finance and insurance, Statistics Canada data indicated Friday.

Analysts in a Reuters poll had predicted monthly GDP would increase by 0.2 percent. Fifteen of the 20 industrial sectors — which Statscan says represents around 80 percent of the economy — posted gains.

The release could well be a pleasant surprise for Bank of Canada Governor Stephen Poloz, who complained earlier this month that economic data heading into the fourth quarter were weaker than expected.

The manufacturing sector grew by 0.7 percent on higher output of machinery, primary metals, chemicals and food. The finance and insurance sector advanced by 0.9 percent on increased activity in bond and money markets.

Wholesale trade grew by 1.0 percent, while utilities were up 1.5 percent on unseasonably cold weather that contributed to higher electricity demand for heating purposes.

more

Nigerian Energy Sector’s Crippling Debts Delay Next Power Plant

Plans to build another privately-financed power station in Nigeria to help end decades of chronic blackouts have been delayed because of concerns about persistent shortfalls in payments for electricity across the sector.

The $1.1 billion Qua Iboe Power Plant being developed by energy infrastructure company Black Rhino and the state-owned Nigerian National Petroleum Corporation won’t get a green light by the end of 2018 as planned and it was unclear when the deal might close, NNPC told Reuters.

The delay is a setback for Africa’s biggest oil producer where 80 million people don’t have access to grid power supplies and it exposes the difficulties in attracting private investment to a sector that successive governments have tried to reform.

The uncertainty surrounding the 540-megawatt Qua Iboe plant stems from the difficulties Nigeria’s first privately-financed independent power project — the 460-megawatt Azura-Edo plant — has encountered since it came online this year.

Azura was meant to be a model for a string of independent power plants financed by international investors. To give them confidence to invest in the first major plant since the power sector was privatized in 2013, the World Bank provided a safeguard known as a partial risk guarantee — meaning the lender would step in if Nigeria defaulted on payments.

Under the current system, the government-owned Nigerian Bulk Electricity Trading company (NBET) buys power from generators and passes it on to distributors who then collect money from customers and reimburse NBET.

But because NBET is not paid in full for the power it buys, generators such as Azura have been partly reimbursed from an emergency central bank loan fund created to keep the sector afloat.

NNPC told Reuters one of the reasons the Qua Iboe plant (QIPP), which is due to be built in the southern state of Akwa Ibom, had been delayed was because NBET appeared reluctant to commit to new projects to avoid increasing its liabilities.

“The continued delay relates to the current cashflow challenges at NBET, as highlighted by the Azura project,” a spokesman for NNPC said in an emailed statement. “This concern is justified by the fact that NBET is yet to see an improvement in collections from DISCOs [distribution companies].”

NBET did not immediately respond to a request for comment on NNPC’s statement about QIPP.

NBET chief executive Marilyn Amobi told Reuters in November that it was hard for the company to work because of poor infrastructure and shortfalls in cash from distributors needed to reimburse generators.

“You don’t have the infrastructure, you don’t have the financial position to do it, you don’t actually have the products, and you don’t have the grid,” she said.

World Bank conditions

NNPC said another problem for QIPP was that the World Bank had made a partial risk guarantee, similar to the one that helped Azura attract investors, contingent on the government’s implementation of an agreed power sector recovery plan.

“In theory it is okay, but the risk is there are delays in the approvals which may impact QIPP,” NNPC said. Power ministry officials and the World Bank have been in talks about long-term structural changes needed to trigger the release of a $1 billion loan to help pay for reforms.

A World Bank spokeswoman said the loan had yet to be submitted to its board for approval and that the Washington-based lender considered the recovery plan to be “critical for de-risking the sector for private investments.”

Problems that need to be tackled include decaying infrastructure, mounting debts, low tariffs for electricity and a dilapidated government-owned grid that would collapse if all the country’s power generators operated at full tilt.

Even though NBET has an agreement to buy 13 gigawatts (GW) from power generators, the system can only cope with distributors sending out an average of 4 GW, according to the ministry of power.

The World Bank spokeswoman confirmed any future guarantees for independent power plants (IPPs) would be linked to the plan’s implementation – because the economic and financial viability of generation capacity expansion was at risk.

A spokeswoman for Black Rhino, which is one of private equity firm Blackstone’s portfolio companies, declined to comment on NNPC’s announcement of a delay to QIPP. When the project was unveiled, Nigerian cement giant Dangote Group was named as a joint venture partner – along with Black Rhino and the Nigerian National Petroleum Corporation.

But a Dangote executive told Reuters on condition of anonymity that the company, owned by Africa’s richest man, Aliko Dangote, had pulled out.

“The huge debt level, and, the fact the IPPs are not making profits, is another reason for prospective investors to be deterred,” he said. “Further, collecting revenue from the distribution companies is also becoming a mirage.”

A Dangote Group spokesman declined to comment on the delay to QIPP, or whether the company had pulled out.

‘Illiquid and insolvent’

The payment problems in the Nigerian power sector were thrust into the spotlight in March when four generating companies filed a lawsuit against the government and Azura.

To ensure the generating companies were paid in full throughout 2017 and 2018, the government created a 701 billion naira ($2.3 billion) loan fund at the central bank to guarantee payments. When the fund was established in 2017, Azura wasn’t part of the calculations.

But when Azura started producing electricity, the fund was also used to pay the new plant to ensure the terms of loan deals guaranteed by the World Bank were not breached. As a result, the other companies were told they would only receive 80 percent of the sums owed, according to the lawsuit filed in March.

The four energy companies want the fund to reimburse them in full, rather than allocating part of the money to the new plant. Azura declined to comment on payments for power generated.

“If the central bank wasn’t paying, the system would collapse,” an official at a multilateral lender said on condition of anonymity. “Qua Iboe IPP would enter a system that is illiquid and insolvent. The liquidity is being provided by the central bank.”

The official said QIPP would need the same partial risk guarantee Azura received to get off the ground, but the handling of payments to Azura by the Nigerian authorities so far meant there was little appetite to offer the same support.

Fola Fagbule, senior vice president and head of advisory at Africa Finance Corporation (AFC) — one of the multilateral lenders that invested in Azura — agreed that the Qua Iboe project would struggle without payment guarantees.

“What you have is an insolvent system,” he said. “It is really difficult to make a case for a project on that scale.”

A person with direct knowledge of QIPP who declined to be named said Azura’s experience was damaging international investors’ view of Nigeria, Africa’s most populous nation.

“There has to be some understanding of how the sector is going to be able to afford new electrons coming into the grid,” the person said. “[Those involved] do not want QIPP to build a project that could just end up in a default situation.”

‘Knotty issues’

Nigeria’s privatized power sector typically does not use meters to provide invoices, bill collections are low and energy tariffs have remained fixed for three years, meaning customers receive unsustainably cheap electricity.

The effect, say industry experts, is that electricity distribution companies recover so little revenue from customers that they pay less than a third of what they owe to generating companies – and that’s why debts have ballooned.

Sunday Oduntan, spokesman for the Association of Nigerian Electricity Distributors, said debt levels in the sector were caused by the artificial suppression of tariffs. He said there was a 1.3 trillion naira ($4.2 billion) market shortfall that meant distributors were unable to invest in improvements.

“You cannot be selling a product below cost price and expect high remittance. The shortfall in the sector is because of the lack of a cost-reflective tariff,” said Oduntan, who speaks on behalf of Nigeria’s 11 electricity distribution companies.

Debts across the sector partly stem from a currency crisis that took hold in 2016, just months after Azura secured its financing. The bulk of power company costs are in U.S. dollars but customers pay for power in naira.

The naira lost about 30 percent of its value against the U.S. dollar in June 2016 but the devaluation was not factored into a government tariff structure that has remained unchanged. Louis Edozien, permanent secretary in the ministry of power, told Reuters there was evidence tariffs must rise, but it was also the responsibility of distributors to improve their collections, partly through better metering and infrastructure.

As for the future of QIPP, the state oil company said it would take six to eight months from whenever NBET executes an agreement to purchase power from the plant before a final investment decision could be taken.

The NNPC spokesman said there were a number of other “knotty issues”, including the completion of a transmission line from the project site. He said QIPP had now agreed in a major concession to pay $20 million for it to be finished.

He also said there was a disagreement between QIPP and the central bank about the exchange rate at which power producers could buy U.S. dollars with naira. He said this had been escalated to the minister of finance.

With the $1 billion World Bank power sector loan on hold for now, the government is considering putting another 600 billion naira into the central bank fund to pay generators when the initial amount runs out early next year, sources said.

It was not clear how the central bank loans to the sector would be repaid.

Central Bank Governor Godwin Emefiele told Reuters that payments from the fund could be made up to February and that the bank was holding talks with World Bank officials.

“The loan negotiations are still in progress with no terminal date yet fixed,” the power ministry’s Edozien said.

($1 = 306.6000 naira)

more

US GDP Grew 3.4 Percent in Q3, Slowed by Falling Exports

US growth in the July-September quarter was slightly slower than previously reported, dragged down by the large drop in exports amid President Donald Trump’s multi-front trade wars.

With hundreds of billions of goods hit by retaliatory tariffs, US exports fell by the largest amount since early 2009 at the height of the global financial crisis.

Gross domestic product expanded by 3.4 percent in the third quarter rather than the 3.5 percent previously reported, due in large measure to the 4.9 percent drop in exports, five-tenths more than the Commerce Department originally estimated.

Goods exports dropped 8.1 percent, the biggest decline since the first three months of 2015.

Trump’s aggressive trade policies, and especially the tariff retaliation from China, has impeded exports, with soybean sales nearly grinding to a halt. The strong US dollar also has made American goods more expensive.

The smaller rise in consumer spending, largely the result of lower fuel costs, also contributed to the downward revision to GDP growth, the Commerce Department said.

Meanwhile, residential investment fell 3.6 percent, only partly offset by 1.1 percent gain in non-residential, or business, investment, data borne out by the slowdown in home construction and sales.

Other data show fourth quarter growth is shaping up to be even more sluggish. Purchases of durable goods — big ticket items like appliances, vehicles and machinery — rose in November compared to October, but much less than expected.

Orders were up 0.8 percent last month, less than half the increase economists had forecast, according to a separate Commerce Department report. That follows a big drop in October, and will drag on GDP in the final quarter of 2018.

Excluding transportation goods, durable goods orders fell 0.3 percent compared to October, and when defense is removed, the drop was 0.1 percent.

Orders are still 8.4 percent higher than they were through November 2017, but have been on a declining trend for three months.

more

Alba the Albino Orangutan Returned to Jungle in Indonesia

The world’s only known albino orangutan climbed trees, foraged for food and began building a nest after being released into a remote Borneo jungle more than a year after conservation officials found her starving and dehydrated in an Indonesian village.

The Borneo Orangutan Survival foundation says the great ape, called Alba after thousands worldwide responded to an appeal for a name, has tripled in weight since being rescued in April last year. Her name means “white” in Latin and “dawn” in Spanish.

Alba and another rehabilitated orangutan, Kika, were released inside Bukit Baka Bukit Raya National Park on Wednesday after a more than 24-hour journey from their rehabilitation center by vehicle, boat and hiking.

The foundation originally planned to create a 5-hectare (12-acre) “forest island” for Alba rather than a release into truly natural habitat because of health issues related to her albinism including poor sight and hearing and the possibility of skin cancer.

But the government’s Natural Resources Conservation Agency and other agencies decided it was appropriate to release Alba into the wild because of her strong physical condition and intrinsically wild behavior.

She will be electronically tracked and regularly monitored by a medical team.

“Alba has no inferiority complex as we imagined before. She is very confident compared to other orangutans,” said veterinarian Agus Fathoni.

“I think the real threat actually comes from humans. What we’re worried about is poaching where this very special condition makes her a target,” he told The Associated Press.

Patrols of Alba’s new home by national park and conservation agency staff will aim to deter poachers, though they admit the number of personnel is limited.

“We don’t have enough to cover all the area of the national park but we’re confident of covering all the patrol lines that we have set,” said national park official Wirasadi Nursubhi

Orangutans, reddish-brown primates known for their gentle temperament and intelligence, are critically endangered and only found in the wild on the Indonesian island of Sumatra and on Borneo, which is divided among Indonesia, Malaysia and Brunei.

The International Union for Conservation of Nature, which declared Borneo’s orangutans critically endangered in 2016, says their numbers have dropped by nearly two-thirds since the early 1970s as plantation agriculture destroyed and fragmented their forest habitat.

The Sumatran orangutan is a separate species and has been critically endangered since 2008.

Alba, approximately five years old, was given final medical tests and anesthetized for the journey to Bukit Baka Bukit Raya.

Workers shouted “Alba’s going home” as her cage was lifted onto a truck at the Nyaru Menteng Rehabilitation Center in Central Kalimantan province on Borneo.

“It’s true this is a big gamble but we hope that with our collaboration we will win the big bet we have made today” said the orangutan foundation’s chief executive Jamartin Sihite after releasing Alba from her cage.

more

NASA Satellite Will Measure the World’s Forests

Forests are often called the lungs of the planet because they produce so much oxygen. But they also store huge amounts of carbon. NASA scientists want to know exactly how much carbon, and so they have just launched a satellite that will finally give them an exact measurement. VOA’s Kevin Enochs reports.

more

Experts Call for Inclusion of Pregnant Women in Vaccine Research

Pregnant women have been systematically overlooked in the development and deployment of new vaccines, undermining their health and their communities’ safety, according to guidelines released this month by an international team of researchers, scientists and health care providers.

The report, developed by the Pregnancy Research Ethics for Vaccines, Epidemics and New Technologies (PREVENT) working group, identifies a cycle of exclusion that prevents pregnant women from accessing the benefits of vaccines.

“There’s a lot of reticence to include pregnant women in research,” said Carleigh Krubiner, the project director and a co-principal investigator for PREVENT.

And that’s led to a shortfall in data about how pregnant women respond to vaccines.

Krubiner, an associate faculty member at the Johns Hopkins Berman Institute of Bioethics, told VOA that researchers and health care providers tend to exclude pregnant women from trials, vaccinations and tracking because they lack evidence of the risks expectant mothers face.

“We continue to have this Catch-22 of not having enough evidence to feel like we can do the research. But if we don’t do the research, we don’t have the evidence,” Krubiner said.

‘There’s a lot of fear’

Concerns over “theoretical harm” drive decisions to exclude pregnant women from interventions, Krubiner said. But the data scientists do have, often from women not known to be pregnant when they received vaccinations, suggest those concerns are overblown.

In the case of rubella, for example, a contagious viral infection, researchers didn’t find a connection between congenital rubella syndrome and the vaccine when thousands of pregnant women were vaccinated before their pregnancy status was known.

“There’s a lot of fear,” Krubiner said. “And there are certainly biologically plausible risks associated with different types of live replicating viral vaccines.”

Live-virus vaccines contain a weakened version of the disease designed to stimulate an immune response in recipients.

“Very often, the benefits of vaccinating do still outweigh the theoretical, or even real harms that may be posed to the fetus,” Krubiner said.

One vaccine known to cause harm to pregnant women and their fetuses, Krubiner added, is for smallpox. But even in that case, she said, if a threat were imminent, pregnant women should get vaccinated, given the seriousness of the disease. The Centers for Disease Control and Prevention support that guidance.

​‘Strongly recommended’

The advice pregnant women receive about vaccination should reflect what’s known about the particular vaccine and the specific circumstances of the outbreak, Krubiner said. 

Recommendations should follow current knowledge about the disease in question, the severity of the threat, and the likelihood of exposure, she added.

But the general guidance is unambiguous.

“At minimum, vaccines should be offered to women, and in many cases they should be strongly recommended,” Krubiner said.

Among those cases is the vaccine for seasonal and pandemic flu, which pregnant women should be urged to receive, in light of the severity of the risks tied to infection — not just for the expectant mother, but the future child as well.

Pregnant women should also be encouraged to receive vaccines for H1N1, also known as swine flu, and DPT, which protects against diphtheria, whooping cough and tetanus.

Institutional change

Involving pregnant women in the benefits of vaccines will require systemic shifts, the PREVENT group said in its report this month.

An important step is to become more proactive in bringing pregnant women into what Krubiner called the “development and research pipeline.” By involving pregnant women early, she said, health care providers aren’t left with the kinds of blind spots about how vaccines will affect expectant mothers and their fetuses that lead to their exclusion.

Even basic information, such as pregnancy status in case reports, sometimes goes untracked, despite being easy to collect and providing insight into the unique burden pregnant women face in disease outbreaks.

More complex data collection will paint a more complete picture. Specific studies could be designed to examine the safety and efficacy of vaccines for pregnant women, for example, or to track effects at different points in gestation.

“Starting anywhere at this point would be better than the dearth of data that we have right now to really try to address the needs of pregnant women and their babies,” Krubiner said.

Lessons learned

Disease outbreaks devastate communities. But they also provide opportunities to better prepare for, and respond to, the next epidemic.

In this year’s Ebola outbreaks in Congo, responders have applied lessons from West Africa’s 2014-16 epidemic to community engagement. And drug trials toward the end of the West Africa outbreak produced evidence about the vaccine that’s now being deployed.

But pregnant women weren’t included in those trials, and researchers collected little in the way of data about the burden pregnant women and their offspring face.

“Pregnant women are continuously getting left out of the benefits of scientific advancement in medicine,” Krubiner said.

“If we continue to fail to collect the kinds of data that we need, to generate the kind of evidence that we need and to also have interventions that meet the broader population’s needs,” Krubiner said, “then we’re just going to continue to perpetuate the cycle.”

more

Report: Distributors, DEA Failed to Slow US Opioid Crisis

A congressional report on prescription pill dumping in West Virginia blames U.S. prescription drug distributors and the Drug Enforcement Administration for not doing enough to help mitigate the nation’s opioid addiction and overdose crisis.

The 324-page report released Wednesday by the House Energy and Commerce Committee followed an 18-month investigation and focused on the three largest U.S. wholesale drug companies, McKesson Corp., Cardinal Health and AmerisourceBergen, and regional distributors.

The report cited examples of massive pill shipments to West Virginia, which has a population of 1.8 million and has by far the nation’s highest death rate from prescription drugs. McKesson shipped an average of 9,650 hydrocodone pills per day in 2007 to a now-closed pharmacy in Kermit, which has a population of about 400. The shipments were 36 times above a monthly dosage shipment threshold the company had established that year.

Compliance questions

The Charleston Gazette-Mail previously cited federal records that showed drug wholesalers shipped 780 million hydrocodone and oxycodone pills to West Virginia from 2007 to 2012, a period when 1,728 people fatally overdosed on the painkillers. Gazette-Mail reporter Eric Eyre won a Pulitzer Prize last year for investigative reporting on the subject.

The committee report calls the shipments “troubling” and said it raises serious questions about compliance with the DEA-administered Controlled Substances Act. Until at least 2010, the DEA didn’t proactively review usage data to combat the diversion of drugs for illicit purposes, the report said.

Drug distributors are required to submit suspicious orders to the DEA, which “still does not have a centralized way to analyze suspicious order reports submitted by drug distributors,” the report said. Instead, suspicious orders are typically reported to local DEA offices, resulting in inconsistent handling under varying regulatory interpretations.

“As the country continues to feel the effects of the opioid crisis, neither distributors nor the DEA can shirk their oversight responsibilities,” the report said.

​Additional rules urged

The report suggests pharmacies with suspicious orders should be subjected to heightened monitoring, Congress should enact additional requirements on suspicious pill orders to clarify database registrant responsibilities, and the DEA should work to provide more real-time data to registrants.

Earlier this year the DEA approved a rule change requiring drugmakers to identify a legitimate need for opioids to justify their production in an attempt to rein in their diversion for abuse.

More than 351,000 people have died of opioid overdoses in the United States since 1999, and far more people die each year from opioid misuse than from traffic accidents or violence, the report said.

“This investigation is a start to establish some accountability and understanding about the epidemic, but this inquiry is only a look at a piece of the overall puzzle,” the report said. “There are other actors involved in the epidemic including manufacturers, pharmacies, physicians, and drug traffickers.”

Company statements

Chesterbrook, Pennsylvania-based AmerisourceBergen said in a statement it has proactively enacted many of the report’s recommendations but has “virtually no interaction with physicians and limited legal ability to gather information on their practices and prescribing behavior.”

Dublin, Ohio-based Cardinal Health said it would “continue to implement rigorous anti-diversion controls.” A company statement said it is an intermediary in the pharmaceutical supply chain that “plays a limited but vital role.”

The DEA and San Francisco-based McKesson Corp. didn’t immediate respond to requests for comment.

more